Inducible nitric oxide synthase expression in melanoma: implications in lymphangiogenesis

Kleinert, 2004, Regulation of the expression of inducible nitric oxide synthase, Eur J Pharmacol, 500, 255, 10.1016/j.ejphar.2004.07.030 Jenkins, 1995, Roles of nitric oxide in tumor growth, Proc Natl Acad Sci USA, 92, 4392, 10.1073/pnas.92.10.4392 Cobbs, 1995, Expression of nitric oxide synthase in human central nervous system tumors, Cancer Res, 55, 727 Thomsen, 1995, Nitric oxide synthase activity in human breast cancer, Br J Cancer, 72, 41, 10.1038/bjc.1995.274 Franchi, 2006, Inducible nitric oxide synthase activity correlates with lymphangiogenesis and vascular endothelial growth factor-C expression in head and neck squamous cell carcinoma, J Pathol, 208, 439, 10.1002/path.1892 Joshi, 1996, Nitric oxide synthase activity is up-regulated in melanoma cell lines: a potential mechanism for metastases formation, Melanoma Res, 6, 121, 10.1097/00008390-199604000-00006 Fukumura, 1998, Role of nitric oxide in angiogenesis and microcirculation in tumors, Cancer Metastasis Rev, 17, 77, 10.1023/A:1005908805527 Ohhashi, 2005, Current topics of physiology and pharmacology in the lymphatic system, Pharmacol Ther, 105, 165, 10.1016/j.pharmthera.2004.10.009 Salvucci, 2001, Antiapoptotic role of endogenous nitric oxide in human melanoma cells, Cancer Res, 61, 318 Tang, 2004, Depletion of endogenous nitric oxide enhances cisplatin-induced apoptosis in a p53-dependent manner in melanoma cell lines, J Biol Chem, 279, 288, 10.1074/jbc.M310821200 Zheng, 2004, Inhibition of nuclear factor-kappaB and nitric oxide by curcumin induces G2/M cell cycle arrest and apoptosis in human melanoma cells, Melanoma Res, 14, 165, 10.1097/01.cmr.0000129374.76399.19 Tschugguel, 1999, Inducible nitric oxide synthase (iNOS) expression may predict distant metastasis in human melanoma, Br J Cancer, 79, 1609, 10.1038/sj.bjc.6690256 Ekmekcioglu, 2000, Inducible nitric oxide synthase and nitrotyrosine in human metastatic melanoma tumors correlate with poor survival, Clin Cancer Res, 6, 4768 Massi, 2001, Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions, J Pathol, 194, 194, 10.1002/1096-9896(200106)194:2<194::AID-PATH851>3.0.CO;2-S Ekmekcioglu, 2003, Negative association of melanoma differentiation-associated gene (mda-7) and inducible nitric oxide synthase (iNOS) in human melanoma: MDA-7 regulates iNOS expression in melanoma cells, Mol Cancer Ther, 2, 9, 10.1186/1476-4598-2-9 Ekmekcioglu, 2006, Tumor iNOS predicts poor survival for stage III melanoma patients, Int J Cancer, 119, 861, 10.1002/ijc.21767 Ahmed, 2000, Expression of the inducible isoform of nitric oxide synthase in pigment cell lesions of the skin, Br J Dermatol, 142, 432, 10.1046/j.1365-2133.2000.03352.x Ambs, 1998, Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression, Cancer Res, 58, 334 Gallo, 1998, Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer, J Natl Cancer Inst, 90, 587, 10.1093/jnci/90.8.587 Reveneau, 1999, Nitric oxide synthase in human breast cancer is associated with tumor grade, proliferation rate, and expression of progesterone receptors, Lab Invest, 79, 1215 Ziche, 1997, Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis, J Clin Invest, 99, 2625, 10.1172/JCI119451 Lin, 2003, Nitric oxide synthase expression in human bladder cancer and its relation to angiogenesis, Urol Res, 31, 232, 10.1007/s00240-003-0302-9 Maeda, 1994, Enhanced vascular permeability in solid tumor is mediated by nitric oxide and inhibited by both new nitric oxide scavenger and nitric oxide synthase inhibitor, Jpn J Cancer Res, 85, 331, 10.1111/j.1349-7006.1994.tb02362.x Tozer, 1997, Inhibition of nitric oxide synthase induces a selective reduction in tumor blood flow that is reversible with L-arginine, Cancer Res, 57, 948 Marshall, 2000, Nitrosation and oxidation in the regulation of gene expression, FASEB J, 14, 1889, 10.1096/fj.00.011rev Nam, 2004, The role of nitric oxide in the particulate matter (PM2.5)-induced NFkappaB activation in lung epithelial cells, Toxicol Lett, 148, 95, 10.1016/j.toxlet.2003.12.007 Massi, 2007, Arginine metabolism in tumor-associated macrophages in cutaneous malignant melanoma: evidence from human and experimental tumors, Hum Pathol, 38, 1516, 10.1016/j.humpath.2007.02.018 Mizuno, 1998, Regulation of the vasomotor activity of lymph microvessels by nitric oxide and prostaglandins, Am J Physiol, 274, R790 Nakamura, 2006, Nitric oxide in breast cancer: induction of vascular endothelial growth factor-C and correlation with metastasis and poor prognosis, Clin Cancer Res, 12, 1201, 10.1158/1078-0432.CCR-05-1269 Skobe, 2001, Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma, Am J Pathol, 159, 893, 10.1016/S0002-9440(10)61765-8 Dadras, 2005, Tumor lymphangiogenesis predicts melanoma metastasis to sentinel lymph nodes, Mod Pathol, 18, 1232, 10.1038/modpathol.3800410 Fonsatti, 2003, Endoglin (CD105): a powerful therapeutic target on tumor-associated angiogenetic blood vessels, Oncogene, 22, 6557, 10.1038/sj.onc.1206813 Straume, 2001, Expression of vascular endothelial growth factor, its receptors (FLT-1, KDR) and TSP-1 related to microvessel density and patient outcome in vertical growth phase melanomas, Am J Pathol, 159, 223, 10.1016/S0002-9440(10)61688-4 Streit, 2003, Angiogenesis, lymphangiogenesis, and melanoma metastasis, Oncogene, 22, 3172, 10.1038/sj.onc.1206457 Padera, 2002, Lymphatic metastasis in the absence of functional intratumor lymphatics, Science, 296, 1883, 10.1126/science.1071420 Dadras, 2003, Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival, Am J Pathol, 162, 1951, 10.1016/S0002-9440(10)64328-3 Straume, 2003, Independent prognostic impact of lymphatic vessel density and presence of low-grade lymphangiogenesis in cutaneous melanoma, Clin Cancer Res, 9, 250 Giorgadze, 2004, Lymphatic vessel density is significantly increased in melanoma, J Cutan Pathol, 31, 672, 10.1111/j.0303-6987.2004.00249.x Shields, 2004, Lymphatic density and metastatic spread in human malignant melanoma, Br J Cancer, 90, 693, 10.1038/sj.bjc.6601571 Valencak, 2004, Selective immunohistochemical staining shows significant prognostic influence of lymphatic and blood vessels in patients with malignant melanoma, Eur J Cancer, 40, 358, 10.1016/j.ejca.2003.09.009 Sahni, 2005, The use of LYVE-1 antibody for detecting lymphatic involvement in patients with malignant melanoma of known sentinel node status, J Clin Pathol, 58, 715, 10.1136/jcp.2004.020123 Massi, 2006, Tumour lymphangiogenesis is a possible predictor of sentinel lymph node status in cutaneous melanoma: a case-control study, J Clin Pathol, 59, 166, 10.1136/jcp.2005.028431 Saharinen, 2004, Lymphatic vasculature: development, molecular regulation and role in tumor metastasis and inflammation, Trends Immunol, 25, 387, 10.1016/j.it.2004.05.003 Shields, 2007, Chemokine-mediated migration of melanoma cells towards lymphatics—a mechanism contributing to metastasis, Oncogene, 26, 2997, 10.1038/sj.onc.1210114